These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 16189905
1. Regulating human gene therapy: legislative overreaction to human subject protection failures. Leavitt WJ. Adm Law Rev; 2001; 53(1):315-41. PubMed ID: 16189905 [No Abstract] [Full Text] [Related]
2. Protecting research subjects--what must be done. Shalala D. N Engl J Med; 2000 Sep 14; 343(11):808-10. PubMed ID: 10984573 [No Abstract] [Full Text] [Related]
3. Research compliance changes will affect rules on protection of human subjects. Maloney DM. Hum Res Rep; 1999 May 14; 14(5):1-2. PubMed ID: 11657776 [No Abstract] [Full Text] [Related]
4. U.S. regulators suspend medical studies at 2 universities. Brainard J, Miller DW. Chron High Educ; 2000 Feb 04; 96(22):A30. PubMed ID: 15744908 [No Abstract] [Full Text] [Related]
5. New policy on research with children is part of trend toward including more research subjects. Maloney DM. Hum Res Rep; 1998 May 04; 13(5):1-2. PubMed ID: 11657189 [No Abstract] [Full Text] [Related]
6. Federal agency keeps review committee after public comments support continuation. Maloney DM. Hum Res Rep; 1997 Jan 04; 12(1):1-2. PubMed ID: 11654603 [No Abstract] [Full Text] [Related]
8. A higher standard for human research. Nat Med; 1999 Jun 04; 5(6):591. PubMed ID: 10371478 [No Abstract] [Full Text] [Related]
9. Duke's hazards. Did medical experiments put patients needlessly at risk? Kaplan S, Brownlee S. US News World Rep; 1999 May 24; 126(20):66-8, 70. PubMed ID: 10387890 [No Abstract] [Full Text] [Related]
10. Agencies said to be slow on research protections reform. Maloney DM. Hum Res Rep; 2001 Jul 24; 16(7):3. PubMed ID: 11933954 [No Abstract] [Full Text] [Related]
11. Data from human research projects will now be available to public. Maloney DM. Hum Res Rep; 2001 Apr 24; 16(4):1-2. PubMed ID: 11883453 [No Abstract] [Full Text] [Related]
12. Making clinical trials safer for human subjects. Baram M. Am J Law Med; 2001 Apr 24; 27(2-3):253-82. PubMed ID: 11467112 [No Abstract] [Full Text] [Related]
13. Protecting research subjects--the crisis at Johns Hopkins. Steinbrook R. N Engl J Med; 2002 Feb 28; 346(9):716-20. PubMed ID: 11870258 [No Abstract] [Full Text] [Related]
14. Mandating research with children. Baylis F. IRB; 1999 Feb 28; 21(1):10-1. PubMed ID: 11657966 [No Abstract] [Full Text] [Related]
15. Protecting human research subjects: ten common problems. Puglisi T. Health Law News; 2000 Jun 28; 13(3):8, 15. PubMed ID: 12542046 [No Abstract] [Full Text] [Related]
16. Human gene therapy research: technological temptations and social control. Baram M, Proctor S, Andalman R, van Eyl D. Genetic Resour; 1993 Jun 28; 7(2):10-5. PubMed ID: 11656942 [No Abstract] [Full Text] [Related]
17. When do the federal regulations allow placebo-controlled trials in children? Miller FG, Wendler D, Wilfond B. J Pediatr; 2003 Feb 28; 142(2):102-7. PubMed ID: 12584527 [No Abstract] [Full Text] [Related]
18. Research involving children: regulations, review boards and reform. Gandhi R. J Health Care Law Policy; 2005 Feb 28; 8(2):264-330. PubMed ID: 16471026 [No Abstract] [Full Text] [Related]
19. United States regulatory requirements for research involving human subjects. J Biolaw Bus; 1998 Feb 28; 1(2):39-53. PubMed ID: 12739542 [No Abstract] [Full Text] [Related]
20. Public regulation of recombinant dna gene therapy. McGarity TO, Shapiro SA. J Leg Med; 1982 Jun 28; 3(2):185-210. PubMed ID: 6981676 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]